Products
Andrew Oster: The power of collaborative care in transitioning to biosimilars
Professor Andrew Oster, Consultant Rheumatologist at the Cabrini Medical Centre in Malvern, Victoria, explains the opportunities biosimilars bring, allowing patients to switch medications. Given the interchangeability of biosimilars, he emphasises …
Eric Chan: Cultivating a relationship of trust between pharmacist and physician
Head of Pharmacy at Blooms The Chemist, Eric Chan emphasises the importance of collaborative care in cultivating a relationship of trust and transparency between a pharmacist and physician. He outlines …
George Tambassis: Empowering and educating pharmacists on biosimilars
George Tambassis, Pharmacist, ex-National Guild President, and chair of the Australian Biosimilar Academy Advisory Board outlines the importance of pharmacist involvement in understanding biosimilars. Given the government supported Community Pharmacy …
Professor Andrew McLachlan presents the recent trends and gaps identified in OA pain management
In this video, Professor Andrew McLachlan discusses how a patient’s health literacy can impact their choice of self-management strategies for OA symptoms and how a lack of condition awareness can …
Professor Andrew McLachlan explains how pharmacists play a critical role in identifying and supporting patients with Osteoarthritis
A recent study found only 3.5% of participants with self-reported OA symptoms sought advice from a pharmacist despite the critical role pharmacists play in helping patients on their pain management …